Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00771147
What this trial is testing

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Who this might be right for
Carcinoma, Renal CellCarcinoma, Renal Cell (Advanced)
Bayer 71
Not applicableStudy completedNCT03273426
What this trial is testing

Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.

Who this might be right for
Breast Neoplasm
Seoul National University Hospital 40
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Testing effectiveness (Phase 2)Looking for participantsNCT06517017
What this trial is testing

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
University of Utah 40
Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04258033
What this trial is testing

PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)

Who this might be right for
Non-small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 145
Testing effectiveness (Phase 2)Study completedNCT01523847
What this trial is testing

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 50
Early research (Phase 1)Active Not RecruitingNCT02477878
What this trial is testing

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphoma+2 more
Bellicum Pharmaceuticals 10
Early research (Phase 1)UnknownNCT03282825
What this trial is testing

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Who this might be right for
Advanced Breast Cancer
Dong Wha Pharmaceutical Co. Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Looking for participantsNCT06214143
What this trial is testing

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd 68
Early research (Phase 1)Looking for participantsNCT04910568
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 186
Post-approval studies (Phase 4)UnknownNCT02348450
What this trial is testing

Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Guangdong Association of Clinical Trials 308
Not applicableNot Yet RecruitingNCT06943690
What this trial is testing

Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery

Who this might be right for
Rectal CancerSurgery
Ruijin Hospital 212
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01593410
What this trial is testing

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 194
Testing effectiveness (Phase 2)Looking for participantsNCT07176182
What this trial is testing

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Who this might be right for
Rectal Cancer PatientsRectal Cancer Stage IIRectal Cancer Stage III
Sixth Affiliated Hospital, Sun Yat-sen University 236
Not applicableNot Yet RecruitingNCT07842835
What this trial is testing

Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China (CLIMB)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
Xiaohui Ren 400
Early research (Phase 1)Study completedNCT02639117
What this trial is testing

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
University of Arizona 4
Testing effectiveness (Phase 2)Study completedNCT00450814
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 48
Next Page